Liu, Wenwen
Meng, Qinqin
Wang, Yafeng
Yang, Chao
Liu, Lili
Wang, Huaiyu
Su, Zaiming
Kong, Guilan
Zhao, Yaohui
Zhang, Luxia
Funding for this research was provided by:
National Natural Science Foundation of China (81771938, 91846101, 81301296)
Peking University (BMU2018MX020, PKU2017LCX05)
National Key Technology R&D Program of the Ministry of Science and Technology of the People's Republic of China (2016YFC1305400)
University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research (BMU20160466)
Article History
Received: 17 November 2019
Accepted: 15 April 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: This study used secondary data from CHARLS for analysis. We were granted permission by the CHARLS project team to access and use the data.
: Not applicable.
: Luxia Zhang received research funding from AstraZeneca. The remaining authors declare that they have no competing interests.